• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 15, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Space station crew cultivates crystals for drug development

Bioengineer by Bioengineer
March 31, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Lawrence DeLucas

Crew members aboard the International Space Station will begin conducting research this week to improve the way we grow crystals on Earth. The information gained from the experiments could speed up the process for drug development, benefiting humans around the world.

Proteins serve an important role within the human body. Without them, the body wouldn't be able to regulate, repair or protect itself. Many proteins are too small to be studied even under a microscope, and must be crystallized in order to determine their 3-D structures. These structures tell researchers how a single protein functions and its involvement in the development of disease. Once modeled, drug developers can use the structure to develop a specific drug to interact with the protein, a process called structure-based drug design.

Two investigations, The Effect of Macromolecular Transport on Microgravity Protein Crystallization (LMM Biophysics 1) and Growth Rate Dispersion as a Predictive Indicator for Biological Crystal Samples Where Quality Can be Improved with Microgravity Growth (LMM Biophysics 3), will study the formation of these crystals, looking at why microgravity-grown crystals often are of higher quality than Earth-grown, and which crystals may benefit from being grown in space.

Rate of Growth – LMM Biophysics 1

Researchers know that crystals grown in space often contain fewer imperfections than those grown on Earth, but the reasoning behind that phenomenon isn't crystal clear. A widely accepted theory in the crystallography community is that the crystals are of higher quality because they grow slower in microgravity due to a lack of buoyancy-induced convection. The only way these protein molecules move in microgravity is by random diffusion, a process that is much slower than movement on Earth.

Another less-explored theory is that a higher level of purification can be achieved in microgravity. A pure crystal may contain thousands of copies of a single protein. Once crystals are returned to Earth and exposed to an X-Ray beam, the X-ray diffraction pattern can be used to mathematically map a protein's structure.

"When you purify proteins to grow crystals, the protein molecules tend to stick to each other in a random fashion," said Lawrence DeLucas, LMM Biophysics 1 primary investigator. "These protein aggregates can then incorporate into the growing crystals causing defects, disturbing the protein alignment, which then reduces the crystal's X-ray diffraction quality."

The theory states that in microgravity, a dimer, or two proteins stuck together, will move much slower than a monomer, or a single protein, giving aggregates less opportunity to incorporate into the crystal.

"You're selecting out for predominantly monomer growth, and minimizing the amount of aggregates that are incorporated into the crystal because they move so much more slowly," said DeLucas.

The LMM Biophysics 1 investigation will put these two theories to the test, to try to understand the reason(s) microgravity-grown crystals are often of superior quality and size compared to their Earth-grown counterparts. Improved X-ray diffraction data results in a more precise protein structure and thereby enhancing our understanding of the protein's biological function and future drug discovery.

Crystal Types – LMM Biophysics 3

As LMM Biophysics 1 studies why space-grown crystals are of higher quality than Earth-grown crystals, LMM Biophysics 3 will take a look at which crystals may benefit from crystallization in space. Research has found that only some proteins crystallized in space benefit from microgravity growth. The shape and surface of the protein that makes up a crystal defines its potential for success in microgravity.

"Some proteins are like building blocks," said Edward Snell, LMM Biophysics 3 primary investigator. "It's very easy to stack them. Those are the ones that won't benefit from microgravity. Others are like jelly beans. When you try and build a nice array of them on the ground, they want to roll away and not be ordered. Those are the ones that benefit from microgravity. What we're trying to do is distinguish the blocks from the jelly beans."

Understanding how different proteins crystallize in microgravity will give researchers a deeper view into how these proteins function, and help to determine which crystals should be transported to the space station for growth.

"We're maximizing the use of a scarce resource, and making sure that every crystal we put up there benefits the scientists on the ground," said Snell.

These crystals could be used in drug development and disease research around the world. Follow @ISS_Research for more information about the science happening on the space station.

###

Media Contact

Rachel Hobson
[email protected]
@NASA_Johnson

http://www.nasa.gov/centers/johnson/home

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

GC/MS Metabolomics Uncovers Thyroid Cancer Biomarkers

October 15, 2025

Predicting US Opioid Deaths with Machine Learning

October 15, 2025

Novel Artificial Neuron Utilizes Molybdenum Disulfide Plasticity

October 15, 2025

CRISPR Screen Spots Sec31A in Alpha Cell Survival

October 15, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1245 shares
    Share 497 Tweet 311
  • New Study Reveals the Science Behind Exercise and Weight Loss

    105 shares
    Share 42 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    101 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    92 shares
    Share 37 Tweet 23

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

GC/MS Metabolomics Uncovers Thyroid Cancer Biomarkers

Predicting US Opioid Deaths with Machine Learning

Novel Artificial Neuron Utilizes Molybdenum Disulfide Plasticity

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 65 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.